February 2011 Issue Table Of Contents
Source: Life Science Leader
Editor’s Note
Ask The Board
Feature
Inside The Industry
- Making Decisions In The Pharma Cold Chain
- A Strategic Weapon To Protect Your IP
- Buttoning Down The Pharma Supply Chain
- How Biomarkers Can Pave The Critical Path For Drug Development
- An Assessment Of 5 Clinical Study Costing Methods
- Real-Time Patient Reporting Could Open The Door To FDA Inspection
- Economic Free Zones And Biopharma Development
Industry Leader